NCT07008963Completed
Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
A Non-interventional, Observational Qualitative Interview Study of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
A cross-sectional, non-interventional, observational study using qualitative patient interviews to explore patient experiences and attitudes toward taking capivasertib + fulvestrant as directed
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 48 (actual)
- First submitted
- 5 May 2025
- Start date
- 31 Jul 2025
- Primary completion date
- 28 Nov 2025
- Lead sponsor
- AstraZeneca
- NCT number
- NCT07008963
What you commit to
- Study type: Observational
- Participants enrolled: 48
- From 31 Jul 2025 to the primary completion date, 28 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who had discontinued capivasertib for more than 6 months before the date of the interview
- Receiving capivasertib in a clinical trial setting
Other
- Unable or unwilling to follow study procedures (including providing informed consent)
- Not proficient in spoken English, as assessed by the moderator
- Patients who are not able to recall instruction for administration of capivasertib in a manner consistent with the labeling (e.g. 4 days on followed by 3 days off)
Who the study is looking for
- Adult (over the age of 18 years)
- Diagnosed with HR+/HER2- metastatic breast cancer
- Received at least 1 week of capivasertib + fulvestrant (Patients will be invited to provide documents demonstrating the use of capivasertib. Patients will be able to participate even if unable to obtain such documentation)
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research Site Coordinator of this site? Confirm its status | Redwood Shores | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.